Purchases and Sales Made in Q2 2021 in Viking Therapeutics, Inc. (VKTX)
This table provides information about the institutional ownership of Viking Therapeutics, Inc. (VKTX) during Q2 2021. The information is specifically focused on institutions that hold shares of Viking Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2021
Q2 2021
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-25.6K- 39.24% |
$133K - $172K
|
39.6K
$2.61M
|
|
|
Aug 05, 2021
Q2 2021
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-25.7K- 43.06% |
$133K - $173K
|
34K
$2.24M
|
|
|
Aug 13, 2021
Q2 2021
|
Virginia Retirement Systems Et Al
Richmond, VA |
SELL
|
- |
-27.7K- 68.56% |
$144K - $186K
|
12.7K
$837K
|
|
|
Aug 11, 2021
Q2 2021
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-29.1K- 22.06% |
$151K - $196K
|
103K
$6.78M
|
|
|
Aug 11, 2021
Q2 2021
|
Fiera Capital Corp
Montreal, A8 |
SELL
|
- |
-30K- 2.69% |
$156K - $202K
|
1.09M
$71.5M
|
|
|
Aug 16, 2021
Q2 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-42K- 4.09% |
$218K - $283K
|
984K
$64.8M
|
|
|
Aug 11, 2021
Q2 2021
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-49.1K- 16.41% |
$255K - $331K
|
250K
$16.5M
|
|
|
Aug 16, 2021
Q2 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-64.1K- 33.49% |
$333K - $432K
|
127K
$8.39M
|
|
|
Aug 13, 2021
Q2 2021
|
Barclays PLC
London, X0 |
SELL
|
- |
-72.3K- 88.37% |
$375K - $486K
|
9.51K
$627K
|
|
|
Aug 11, 2021
Q2 2021
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-72.7KClosed |
$377K - $489K
|
0
$0
|
|
|
Aug 03, 2021
Q2 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-86.6K- 89.11% |
$449K - $583K
|
10.6K
$697K
|
|
|
Aug 17, 2021
Q2 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-127K- 68.35% |
$660K - $856K
|
58.9K
$3.88M
|
|
|
Aug 13, 2021
Q2 2021
|
California Public Employees Retirement System
Sacramento, CA |
SELL
|
- |
-133KClosed |
$692K - $897K
|
0
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
SELL
|
- |
-138K- 45.02% |
$714K - $926K
|
168K
$11.1M
|
|
|
Aug 11, 2021
Q2 2021
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-142K- 35.42% |
$739K - $958K
|
259K
$17.1M
|
|
|
Aug 10, 2021
Q2 2021
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-163K- 46.71% |
$844K - $1.09M
|
185K
$12.2M
|
|
|
Aug 16, 2021
Q2 2021
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-200K- 27.6% |
$1.04M - $1.35M
|
525K
$34.6M
|
|
|
Aug 10, 2021
Q2 2021
|
Aviva PLC
|
SELL
|
- |
-207KClosed |
$1.08M - $1.4M
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-295K- 26.26% |
$1.53M - $1.98M
|
828K
$54.5M
|
|
|
Aug 16, 2021
Q2 2021
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-364KClosed |
$1.89M - $2.45M
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.8M- 26.51% |
$9.33M - $12.1M
|
4.99M
$328M
|